AustralieFrV1, PubMed, Curation, bibRecord, 003714

Plasma lipidomic profiling of treated HIV-positive individuals and the implications for cardiovascular risk prediction.

Identifieur interne : 003714 ( PubMed/Curation ); précédent : 003713; suivant : 003715

Plasma lipidomic profiling of treated HIV-positive individuals and the implications for cardiovascular risk prediction.

Auteurs : Gerard Wong [Australie] ; Janine M. Trevillyan [Australie] ; Benoit Fatou ; Michelle Cinel [Australie] ; Jacquelyn M. Weir [Australie] ; Jennifer F. Hoy [Australie] ; Peter J. Meikle [Australie]

Source :

PloS one [ 1932-6203 ] ; 2014.

RBID : pubmed:24733512

Descripteurs français

KwdFr :
- Adulte, Adulte d'âge moyen, Facteurs de risque, Femelle, Humains, Lipides (sang), Maladies cardiovasculaires (étiologie), Modèles biologiques, Mâle, Métabolisme des lipides, Reproductibilité des résultats, Séropositivité VIH (), Séropositivité VIH (sang), Séropositivité VIH (traitement médicamenteux).
MESH :
- sang : Lipides, Séropositivité VIH.
- traitement médicamenteux : Séropositivité VIH.
- étiologie : Maladies cardiovasculaires.
- Adulte, Adulte d'âge moyen, Facteurs de risque, Femelle, Humains, Modèles biologiques, Mâle, Métabolisme des lipides, Reproductibilité des résultats, Séropositivité VIH.

English descriptors

KwdEn :
- Adult, Cardiovascular Diseases (etiology), Female, HIV Seropositivity (blood), HIV Seropositivity (complications), HIV Seropositivity (drug therapy), Humans, Lipid Metabolism, Lipids (blood), Male, Middle Aged, Models, Biological, Reproducibility of Results, Risk Factors.
MESH :
- chemical , blood : Lipids.
- blood : HIV Seropositivity.
- complications : HIV Seropositivity.
- drug therapy : HIV Seropositivity.
- etiology : Cardiovascular Diseases.
- Adult, Female, Humans, Lipid Metabolism, Male, Middle Aged, Models, Biological, Reproducibility of Results, Risk Factors.

Abstract

The increased risk of coronary artery disease in human immunodeficiency virus (HIV) positive patients is collectively contributed to by the human immunodeficiency virus and antiretroviral-associated dyslipidaemia. In this study, we investigate the characterisation of the plasma lipid profiles of treated HIV patients and the relationship of 316 plasma lipid species across multiple lipid classes with the risk of future cardiovascular events in HIV-positive patients.

DOI: 10.1371/journal.pone.0094810
PubMed: 24733512

Links toward previous steps (curation, corpus...)

to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :003828

Links to Exploration step

pubmed:24733512

Curation

No country items

Benoit Fatou

<affiliation><nlm:affiliation>Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia; University of Sciences and Technologies of Lille, Lille France.</nlm:affiliation>
<wicri:noCountry code="subField">Lille France</wicri:noCountry>
</affiliation>

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Plasma lipidomic profiling of treated HIV-positive individuals and the implications for cardiovascular risk prediction.</title>
<author><name sortKey="Wong, Gerard" sort="Wong, Gerard" uniqKey="Wong G" first="Gerard" last="Wong">Gerard Wong</name>
<affiliation wicri:level="1"><nlm:affiliation>Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Baker IDI Heart and Diabetes Institute, Melbourne, Victoria</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Trevillyan, Janine M" sort="Trevillyan, Janine M" uniqKey="Trevillyan J" first="Janine M" last="Trevillyan">Janine M. Trevillyan</name>
<affiliation wicri:level="1"><nlm:affiliation>Infectious Diseases Unit, Alfred Hospital, Melbourne, Victoria, Australia; Department of Infectious Diseases, Faculty of Medicine, Nursing and Health Science, Monash University, Victoria, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Infectious Diseases Unit, Alfred Hospital, Melbourne, Victoria, Australia; Department of Infectious Diseases, Faculty of Medicine, Nursing and Health Science, Monash University, Victoria</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Fatou, Benoit" sort="Fatou, Benoit" uniqKey="Fatou B" first="Benoit" last="Fatou">Benoit Fatou</name>
<affiliation><nlm:affiliation>Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia; University of Sciences and Technologies of Lille, Lille France.</nlm:affiliation>
<wicri:noCountry code="subField">Lille France</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Cinel, Michelle" sort="Cinel, Michelle" uniqKey="Cinel M" first="Michelle" last="Cinel">Michelle Cinel</name>
<affiliation wicri:level="1"><nlm:affiliation>Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Baker IDI Heart and Diabetes Institute, Melbourne, Victoria</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Weir, Jacquelyn M" sort="Weir, Jacquelyn M" uniqKey="Weir J" first="Jacquelyn M" last="Weir">Jacquelyn M. Weir</name>
<affiliation wicri:level="1"><nlm:affiliation>Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Baker IDI Heart and Diabetes Institute, Melbourne, Victoria</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Hoy, Jennifer F" sort="Hoy, Jennifer F" uniqKey="Hoy J" first="Jennifer F" last="Hoy">Jennifer F. Hoy</name>
<affiliation wicri:level="1"><nlm:affiliation>Infectious Diseases Unit, Alfred Hospital, Melbourne, Victoria, Australia; Department of Infectious Diseases, Faculty of Medicine, Nursing and Health Science, Monash University, Victoria, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Infectious Diseases Unit, Alfred Hospital, Melbourne, Victoria, Australia; Department of Infectious Diseases, Faculty of Medicine, Nursing and Health Science, Monash University, Victoria</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Meikle, Peter J" sort="Meikle, Peter J" uniqKey="Meikle P" first="Peter J" last="Meikle">Peter J. Meikle</name>
<affiliation wicri:level="1"><nlm:affiliation>Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Baker IDI Heart and Diabetes Institute, Melbourne, Victoria</wicri:regionArea>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2014">2014</date>
<idno type="RBID">pubmed:24733512</idno>
<idno type="pmid">24733512</idno>
<idno type="doi">10.1371/journal.pone.0094810</idno>
<idno type="wicri:Area/PubMed/Corpus">003828</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">003828</idno>
<idno type="wicri:Area/PubMed/Curation">003714</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">003714</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Plasma lipidomic profiling of treated HIV-positive individuals and the implications for cardiovascular risk prediction.</title>
<author><name sortKey="Wong, Gerard" sort="Wong, Gerard" uniqKey="Wong G" first="Gerard" last="Wong">Gerard Wong</name>
<affiliation wicri:level="1"><nlm:affiliation>Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Baker IDI Heart and Diabetes Institute, Melbourne, Victoria</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Trevillyan, Janine M" sort="Trevillyan, Janine M" uniqKey="Trevillyan J" first="Janine M" last="Trevillyan">Janine M. Trevillyan</name>
<affiliation wicri:level="1"><nlm:affiliation>Infectious Diseases Unit, Alfred Hospital, Melbourne, Victoria, Australia; Department of Infectious Diseases, Faculty of Medicine, Nursing and Health Science, Monash University, Victoria, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Infectious Diseases Unit, Alfred Hospital, Melbourne, Victoria, Australia; Department of Infectious Diseases, Faculty of Medicine, Nursing and Health Science, Monash University, Victoria</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Fatou, Benoit" sort="Fatou, Benoit" uniqKey="Fatou B" first="Benoit" last="Fatou">Benoit Fatou</name>
<affiliation><nlm:affiliation>Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia; University of Sciences and Technologies of Lille, Lille France.</nlm:affiliation>
<wicri:noCountry code="subField">Lille France</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Cinel, Michelle" sort="Cinel, Michelle" uniqKey="Cinel M" first="Michelle" last="Cinel">Michelle Cinel</name>
<affiliation wicri:level="1"><nlm:affiliation>Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Baker IDI Heart and Diabetes Institute, Melbourne, Victoria</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Weir, Jacquelyn M" sort="Weir, Jacquelyn M" uniqKey="Weir J" first="Jacquelyn M" last="Weir">Jacquelyn M. Weir</name>
<affiliation wicri:level="1"><nlm:affiliation>Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Baker IDI Heart and Diabetes Institute, Melbourne, Victoria</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Hoy, Jennifer F" sort="Hoy, Jennifer F" uniqKey="Hoy J" first="Jennifer F" last="Hoy">Jennifer F. Hoy</name>
<affiliation wicri:level="1"><nlm:affiliation>Infectious Diseases Unit, Alfred Hospital, Melbourne, Victoria, Australia; Department of Infectious Diseases, Faculty of Medicine, Nursing and Health Science, Monash University, Victoria, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Infectious Diseases Unit, Alfred Hospital, Melbourne, Victoria, Australia; Department of Infectious Diseases, Faculty of Medicine, Nursing and Health Science, Monash University, Victoria</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Meikle, Peter J" sort="Meikle, Peter J" uniqKey="Meikle P" first="Peter J" last="Meikle">Peter J. Meikle</name>
<affiliation wicri:level="1"><nlm:affiliation>Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Baker IDI Heart and Diabetes Institute, Melbourne, Victoria</wicri:regionArea>
</affiliation>
</author>
</analytic>
<series><title level="j">PloS one</title>
<idno type="eISSN">1932-6203</idno>
<imprint><date when="2014" type="published">2014</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term>
<term>Cardiovascular Diseases (etiology)</term>
<term>Female</term>
<term>HIV Seropositivity (blood)</term>
<term>HIV Seropositivity (complications)</term>
<term>HIV Seropositivity (drug therapy)</term>
<term>Humans</term>
<term>Lipid Metabolism</term>
<term>Lipids (blood)</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Models, Biological</term>
<term>Reproducibility of Results</term>
<term>Risk Factors</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Adulte</term>
<term>Adulte d'âge moyen</term>
<term>Facteurs de risque</term>
<term>Femelle</term>
<term>Humains</term>
<term>Lipides (sang)</term>
<term>Maladies cardiovasculaires (étiologie)</term>
<term>Modèles biologiques</term>
<term>Mâle</term>
<term>Métabolisme des lipides</term>
<term>Reproductibilité des résultats</term>
<term>Séropositivité VIH ()</term>
<term>Séropositivité VIH (sang)</term>
<term>Séropositivité VIH (traitement médicamenteux)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="blood" xml:lang="en"><term>Lipids</term>
</keywords>
<keywords scheme="MESH" qualifier="blood" xml:lang="en"><term>HIV Seropositivity</term>
</keywords>
<keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>HIV Seropositivity</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>HIV Seropositivity</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Cardiovascular Diseases</term>
</keywords>
<keywords scheme="MESH" qualifier="sang" xml:lang="fr"><term>Lipides</term>
<term>Séropositivité VIH</term>
</keywords>
<keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Séropositivité VIH</term>
</keywords>
<keywords scheme="MESH" qualifier="étiologie" xml:lang="fr"><term>Maladies cardiovasculaires</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Adult</term>
<term>Female</term>
<term>Humans</term>
<term>Lipid Metabolism</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Models, Biological</term>
<term>Reproducibility of Results</term>
<term>Risk Factors</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Adulte</term>
<term>Adulte d'âge moyen</term>
<term>Facteurs de risque</term>
<term>Femelle</term>
<term>Humains</term>
<term>Modèles biologiques</term>
<term>Mâle</term>
<term>Métabolisme des lipides</term>
<term>Reproductibilité des résultats</term>
<term>Séropositivité VIH</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">The increased risk of coronary artery disease in human immunodeficiency virus (HIV) positive patients is collectively contributed to by the human immunodeficiency virus and antiretroviral-associated dyslipidaemia. In this study, we investigate the characterisation of the plasma lipid profiles of treated HIV patients and the relationship of 316 plasma lipid species across multiple lipid classes with the risk of future cardiovascular events in HIV-positive patients.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">24733512</PMID>
<DateCreated><Year>2014</Year>
<Month>04</Month>
<Day>15</Day>
</DateCreated>
<DateCompleted><Year>2015</Year>
<Month>05</Month>
<Day>28</Day>
</DateCompleted>
<DateRevised><Year>2017</Year>
<Month>02</Month>
<Day>20</Day>
</DateRevised>
<Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>9</Volume>
<Issue>4</Issue>
<PubDate><Year>2014</Year>
</PubDate>
</JournalIssue>
<Title>PloS one</Title>
<ISOAbbreviation>PLoS ONE</ISOAbbreviation>
</Journal>
<ArticleTitle>Plasma lipidomic profiling of treated HIV-positive individuals and the implications for cardiovascular risk prediction.</ArticleTitle>
<Pagination><MedlinePgn>e94810</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0094810</ELocationID>
<Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The increased risk of coronary artery disease in human immunodeficiency virus (HIV) positive patients is collectively contributed to by the human immunodeficiency virus and antiretroviral-associated dyslipidaemia. In this study, we investigate the characterisation of the plasma lipid profiles of treated HIV patients and the relationship of 316 plasma lipid species across multiple lipid classes with the risk of future cardiovascular events in HIV-positive patients.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">In a retrospective case-control study, we analysed plasma lipid profiles of 113 subjects. Cases (n = 23) were HIV-positive individuals with a stored blood sample available 12 months prior to their diagnosis of coronary artery disease (CAD). They were age and sex matched to HIV-positive individuals without a diagnosis of CAD (n = 45) and with healthy HIV-negative volunteers (n = 45).</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Association of plasma lipid species and classes with HIV infection and cardiovascular risk in HIV were determined. In multiple logistic regression, we identified 83 lipids species and 7 lipid classes significantly associated with HIV infection and a further identified 74 lipid species and 8 lipid classes significantly associated with future cardiovascular events in HIV-positive subjects. Risk prediction models incorporating lipid species attained an area under the receiver operator characteristic curve (AUC) of 0.78 (0.775, 0.785)) and outperformed all other tested markers and risk scores in the identification of HIV-positive subjects with increased risk of cardiovascular events.</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Our results demonstrate that HIV-positive patients have significant differences in their plasma lipid profiles compared with healthy HIV-negative controls and that numerous lipid species were significantly associated with elevated cardiovascular risk. This suggests a potential novel application for plasma lipids in cardiovascular risk screening of HIV-positive patients.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wong</LastName>
<ForeName>Gerard</ForeName>
<Initials>G</Initials>
<AffiliationInfo><Affiliation>Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Trevillyan</LastName>
<ForeName>Janine M</ForeName>
<Initials>JM</Initials>
<AffiliationInfo><Affiliation>Infectious Diseases Unit, Alfred Hospital, Melbourne, Victoria, Australia; Department of Infectious Diseases, Faculty of Medicine, Nursing and Health Science, Monash University, Victoria, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Fatou</LastName>
<ForeName>Benoit</ForeName>
<Initials>B</Initials>
<AffiliationInfo><Affiliation>Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia; University of Sciences and Technologies of Lille, Lille France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Cinel</LastName>
<ForeName>Michelle</ForeName>
<Initials>M</Initials>
<AffiliationInfo><Affiliation>Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Weir</LastName>
<ForeName>Jacquelyn M</ForeName>
<Initials>JM</Initials>
<AffiliationInfo><Affiliation>Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Hoy</LastName>
<ForeName>Jennifer F</ForeName>
<Initials>JF</Initials>
<AffiliationInfo><Affiliation>Infectious Diseases Unit, Alfred Hospital, Melbourne, Victoria, Australia; Department of Infectious Diseases, Faculty of Medicine, Nursing and Health Science, Monash University, Victoria, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Meikle</LastName>
<ForeName>Peter J</ForeName>
<Initials>PJ</Initials>
<AffiliationInfo><Affiliation>Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2014</Year>
<Month>04</Month>
<Day>14</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>PLoS One</MedlineTA>
<NlmUniqueID>101285081</NlmUniqueID>
<ISSNLinking>1932-6203</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D008055">Lipids</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>J Clin Endocrinol Metab. 2005 Feb;90(2):755-60</RefSource>
<PMID Version="1">15522931</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Atheroscler Thromb. 2007 Feb;14(1):12-8</RefSource>
<PMID Version="1">17332687</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Arterioscler Thromb Vasc Biol. 2011 Nov;31(11):2723-32</RefSource>
<PMID Version="1">21903946</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Lipid Res. 2013 Oct;54(10):2898-908</RefSource>
<PMID Version="1">23868910</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Circulation. 2008 Feb 12;117(6):743-53</RefSource>
<PMID Version="1">18212285</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Clin Endocrinol Metab. 1993 Mar;76(3):559-65</RefSource>
<PMID Version="1">8445011</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Curr Infect Dis Rep. 2004 Dec;6(6):471-482</RefSource>
<PMID Version="1">15538985</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Clin Infect Dis. 2007 Jun 15;44(12):1625-31</RefSource>
<PMID Version="1">17516408</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Scand J Infect Dis. 2000;32(2):111-23</RefSource>
<PMID Version="1">10826894</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Top HIV Med. 2010 Aug-Sep;18(3):112-8</RefSource>
<PMID Version="1">20921577</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Circ Cardiovasc Genet. 2014 Feb;7(1):71-9</RefSource>
<PMID Version="1">24448739</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Atherosclerosis. 2005 Jan;178(1):165-72</RefSource>
<PMID Version="1">15585214</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>AIDS. 2009 Mar 13;23(5):589-96</RefSource>
<PMID Version="1">19177019</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2013;8(10):e76577</RefSource>
<PMID Version="1">24116121</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Free Radic Biol Med. 1995 Oct;19(4):523-8</RefSource>
<PMID Version="1">7590404</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Ann Intern Med. 2007 Jan 16;146(2):87-95</RefSource>
<PMID Version="1">17227932</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Sex Health. 2013 May;10(2):97-101</RefSource>
<PMID Version="1">23256968</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>AIDS. 2011 Jan 14;25(2):185-95</RefSource>
<PMID Version="1">21150555</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Clin Endocrinol Metab. 2007 Jul;92(7):2506-12</RefSource>
<PMID Version="1">17456578</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Arterioscler Thromb Vasc Biol. 2006 Jan;26(1):7-9</RefSource>
<PMID Version="1">16373621</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Leukoc Biol. 1992 Jul;52(1):111-4</RefSource>
<PMID Version="1">1640166</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Antiviral Res. 2000 Aug;47(2):121-9</RefSource>
<PMID Version="1">10996400</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2008;3(8):e3003</RefSource>
<PMID Version="1">18714345</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Antivir Ther. 2005;10(5):585-91</RefSource>
<PMID Version="1">16152752</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Metabolism. 2006 Feb;55(2):175-82</RefSource>
<PMID Version="1">16423623</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Eur J Cardiovasc Prev Rehabil. 2010 Oct;17(5):491-501</RefSource>
<PMID Version="1">20543702</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>N Engl J Med. 2003 Nov 20;349(21):1993-2003</RefSource>
<PMID Version="1">14627784</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Lipid Res. 2009 Mar;50(3):574-85</RefSource>
<PMID Version="1">18832345</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>JAMA. 2007 Feb 14;297(6):611-9</RefSource>
<PMID Version="1">17299196</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2013;8(9):e74341</RefSource>
<PMID Version="1">24086336</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Lancet. 2003 Jul 5;362(9377):22-9</RefSource>
<PMID Version="1">12853195</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D002318" MajorTopicYN="N">Cardiovascular Diseases</DescriptorName>
<QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006679" MajorTopicYN="N">HIV Seropositivity</DescriptorName>
<QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName>
<QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
<QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D050356" MajorTopicYN="N">Lipid Metabolism</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008055" MajorTopicYN="N">Lipids</DescriptorName>
<QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008954" MajorTopicYN="N">Models, Biological</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D015203" MajorTopicYN="N">Reproducibility of Results</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<OtherID Source="NLM">PMC3986244</OtherID>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2014</Year>
<Month>01</Month>
<Day>08</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2014</Year>
<Month>03</Month>
<Day>20</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2014</Year>
<Month>4</Month>
<Day>16</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2014</Year>
<Month>4</Month>
<Day>16</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2015</Year>
<Month>5</Month>
<Day>29</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>epublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">24733512</ArticleId>
<ArticleId IdType="doi">10.1371/journal.pone.0094810</ArticleId>
<ArticleId IdType="pii">PONE-D-14-00741</ArticleId>
<ArticleId IdType="pmc">PMC3986244</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/PubMed/Curation

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003714 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 003714 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Asie
   |area=    AustralieFrV1
   |flux=    PubMed
   |étape=   Curation
   |type=    RBID
   |clé=     pubmed:24733512
   |texte=   Plasma lipidomic profiling of treated HIV-positive individuals and the implications for cardiovascular risk prediction.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i   -Sk "pubmed:24733512" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd   \
       | NlmPubMed2Wicri -a AustralieFrV1

This area was generated with Dilib version V0.6.33.
Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024

	Serveur d'exploration sur les relations entre la France et l'Australie
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration sur les relations entre la France et l'Australie

Plasma lipidomic profiling of treated HIV-positive individuals and the implications for cardiovascular risk prediction.

Plasma lipidomic profiling of treated HIV-positive individuals and the implications for cardiovascular risk prediction.

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Links to Exploration step

Curation

No country items

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki